MarginsXMarginsX
Home › Markets › Health Care › IART

Integra LifeSciences Holdings Corporation (IART)

IART trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$13.98
-2.92% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$1.6B
+1.5% on 2024
Net income · 2025
-$516.5M
-31.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/917520/000091752026000011/0000917520-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerIART on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000917520
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.6B
Net income-$516.5M
Operating income-$493.4M
Net margin-31.6%
Operating margin-30.2%
Revenue growth+1.5%
Cash$235.0M
Total assets$3.6B
P/E (computed)Net income was not positive
P/S (computed)0.7×

Warning signs

Cash runway
Cash-flow positive
$252.3M cash at September 30, 2026
Share count, 1 year
-0.1%
2025-10-29 to 2026-10-22 · -0.5% over 3 years
Going-concern doubt
No
10-Q filed October 23, 2026
Insider net buying, 12 months
$102K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-23
Cash and burn$252.3M cash; operating cash flow $35.1M a quarter.Report 2026-09-30
Shares outstanding77,800,976 (2026-10-22); 77,892,111 a year earlier; 78,175,803 three years earlier.Cover page 2026-10-22
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-26
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Florham Park, New Jersey, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $102K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$411.2M$14.9M$96.0M$252.3M$697.5M$1.7B10-Q 2026-10-23
Q2 2026
2026-06-30
$418.8M$4.5M$22.8M$214.4M$707.2M$1.6B10-Q 2026-07-29
Q1 2026
2026-03-31
$391.9M-$4.6M$9.8M$236.8M$716.9M$1.6B10-Q 2026-05-05
Q4 2025
2025-12-31
$434.9M-$1.7M$11.8M$235.0M$726.6M$1.6B10-K 2026-02-26
Q3 2025
2025-09-30
$402.1M-$5.4M$40.9M$232.2M$736.3M$1.6B10-Q 2026-10-23
Q2 2025
2025-06-30
$415.6M-$484.1M$8.9M$217.9M$745.9M$1.6B10-Q 2026-07-29
Q1 2025
2025-03-31
$382.7M-$25.3M-$11.3M$239.1M$755.6M$1.6B10-Q 2026-05-05
Q4 2024
2024-12-31
$442.6M$19.4M$50.7M$246.4M$760.5M$1.6B10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-02-26
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-10-23
Latest current report8-K2026-10-21
Latest proxyDEFA14A2026-05-05

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+7.3%
1 month+4.0%
3 months-21.1%
Year to date+15.9%
1 year+19.6%
From 52-week high-27.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
IRMDiRadimed Corporation$84.84-0.60%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
SIBNSI-BONE Inc.$23.41-0.13%$1.1B
ATECAlphatec Holdings Inc.$6.78-4.10%$1.1B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
AORTArtivion Inc.$18.47-3.30%$901.1M
NVCRNovoCure Limited$11.30-4.48%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier